_EVENT>> Personalized Medicine in Europe: What will it Take to Succeed ?, 8th December 2011, Luxembourg
_{The European PErsonalised MEDicine association (EPEMED), the IBBL and the Ministry of the Economy and Foreign Trade of the Grand Duchy of Luxembourg are delighted to announce the next EPEMED International Conference: "Personalised Medicine in Europe : what will it take to succeed ?".}

_{Read more > (EN) - 8th December 2011, Novotel Hotel Kirchberg, Luxembourg}

_NEWS>> The Luxembourg Personalized Medicine Consortium (PMC) is "on the right track", confirm international peers
_{The Luxembourg Personalized Medicine Consortium (PMC)is "on the right track", confirmed international scientists from the Scientific Advisory Board during the two-day PMC Retreat on 24th and 25th November 2011 in Mondorf, Luxembourg. The PMC has been operating for just over a year now, and the scientists involved asked their international peers for a critical review of their plans. The results of a two-day retreat: they have made a very good start on their programs, meaning the PMC has an appropriate strategic setup.}

_{Read more > (EN) - 25th November 2011, Mondorf, Luxembourg}

_EVENT>> Open Lecture: Personalising Cancer Therapy: From Lab to Trials to Policy, 12th October 2011, Luxembourg

_{The IBBL and the Laboratory of Experimental Hemato-Oncology of the Centre de Recherche Public – Santé (CRP-Santé) are organising an exclusive open lecture entitled "Personalising Cancer Therapy: From Labs to Trials to Policy" presented by Elizabeth A. Eisenhauer, MD, FRCP.}

_{Read more > (EN) - 12th October 2011, Lecture Hall of Centre Hospitalier de Luxembourg (CHL)} 

_{NEWS >>} Premier pas vers un programme de recherche commun sur le diabète entre le Canada, le Qatar et le Luxembourg

_{Le diabète de type 2 est une maladie qui s’est développée de  manière spectaculaire au cours des 30 dernières années et qui devrait augmenter d’au moins 20 % en Europe d’ici 25 ans. Il s’agit d’une maladie complexe régie par de multiples facteurs à risque. Un panel d’experts provenant du Canada, Qatar et Luxembourg se réunira les mercredi 27 et jeudi 28 septembre à Luxembourg pour discuter d’un programme de recherche commun permettant de mieux comprendre et  combattre cette maladie.} 

_{Read more > (FR) - 27th September 2011}

_EVENT>> IBBL organizes the 2011 Lung Cancer Conference

_{Le cancer du poumon : vers des solutions concrètes et adaptées aux patients. Le cancer du poumon est une maladie très compliquée à soigner et tue chaque année 170 personnes au Luxembourg. Un panel d’experts de renommée mondiale se réunira les 11 et 12 février à Luxembourg pour discuter des nouvelles perspectives de traitement personnalisé offertes par l’utilisation de la biologie moléculaire.}

_{Read more > (FR) - 11th February 2011} 

_NEWS>> WaferGen and Integrated BioBank of Luxembourg (IBBL) Sign Strategic Agreement

_{WaferGen and Integrated BioBank of Luxembourg (IBBL) Sign Strategic Agreement for Molecular Diagnostic Research Collaboration and Purchase of SmartChip System. Fremont, Calif., and Luxembourg, December 16, 2010 -- WaferGen Biosystems, Inc. (OTCBB:WGBS), a leading developer of state-of-the-art genomic analysis systems, and the Integrated BioBank of Luxembourg (IBBL) today announced an agreement to establish a strategic relationship that will expand the use of the WaferGen SmartChip Real-Time PCR system throughout Europe and advance personalized medicine.}

_{Read more > (EN) - 16th December 2010}

_NEWS>> Life Technologies and the Integrated Biobank of Luxembourg Form Strategic Partnership

_{Sequencing of biospecimen samples to advance disease research... Life Technologies and the Integrated Biobank of Luxembourg Form Strategic Partnership Sequencing of biospecimen samples to advance disease research. CARLSBAD, Calif., and Luxembourg – March 23rd, 2010 – During an official visit of the Translational Genomics Research Institute (TGen) by H.R.H. Prince Guillaume, Hereditary Grand Duke of Luxembourg and Jeannot Krecké, Luxembourg’s Minister for the Economy & Foreign Trade, Life Technologies Corporation (NASDAQ: LIFE) and the Integrated Biobank of Luxembourg (IBBL) today announced a strategic partnership aimed at advancing the field of personalized medicine and yielding greater insights into the genetic causes of disease.}

_{Read more > (EN - FR)  - 23rd March 2010}

_EVENT>> Ministers and Pioneer Scientists Open IBBL

_{Luxembourg's international biobank to accelerate clinical research and advance future of healthcare... Ministers and pioneer scientists open Luxembourg’s international biobank to accelerate clinical research and advance future healthcare. The Integrated BioBank of Luxembourg (IBBL) opened its facilities today, with a Grand Opening Ceremony led by Luxembourg’s leading academic institutions, Government Ministers and pioneer scientists from IBBL’s international collaborative partnerships. Today’s official opening marks the beginning of Luxembourg’s bid to become a centre of excellence for biomedical research, serving Luxembourg’s economy and healthcare system.}

_{Read more > (EN) - 25th February 2010}